Scientists probe link between weight loss and arthritis relief
NCT ID NCT07443956
Summary
This study aims to understand how weight loss (using a medication called tirzepatide) and an arthritis drug (ixekizumab) change the body's tissues in people with psoriatic arthritis and obesity. Researchers will take small samples of skin, joint, and fat tissue from 45 participants before and after treatment to see what happens at a molecular level. The goal is to gather knowledge about how these treatments work, not to test their effectiveness for symptom relief.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NHS Greater Glasgow and Clyde
Glasgow, Scotland, G12 0XH, United Kingdom
Contact
Contact
Contact
-
The Newcastle Upon Tyne Hospitals NHS Foundation Trust
Newcastle upon Tyne, England, NE7 7DN, United Kingdom
Contact
-
University Hospitals Birmingham NHS Foundation Trust
Birmingham, England, B12 2GW, United Kingdom
Contact
-
University Hospitals Coventry and Warwickshire NHS Trust
Coventry, England, CV2 2DX, United Kingdom
Contact
Conditions
Explore the condition pages connected to this study.